NewsNational News

Actions

Diabetes drug with high levels of cancer-causing elements recalled

metformin-hydrochloride-recall-1602252358.jpg
Posted at 10:19 AM, Oct 09, 2020
and last updated 2020-10-09 12:19:57-04

WASHINGTON — A popular diabetes drug is being recalled after it was found to contain high levels of a cancer-causing agent.

The Food and Drug Administration announced Marksans Pharma Limited is extending a previous recall issued in June that included Metformin Hydrochloride Extended-Release tablets.

The tables are used to treat Type 2 diabetes.

Tests showed the tablets contained levels of NDMA, which is considered a probable human carcinogen, higher than acceptable daily limits.

The recall applies to tablets between 500 mg and 750 mg sold under the name Time-Cap Labs, Inc.